Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Cash Flows From Operating Activities:
Net loss	$ (230,983)		$ (165,663)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	58,785		60,129
Loss (gain) on asset sales / impairments, net	13,491		(4,693)
Non-cash reorganization items	0		12,301
Deferred income taxes	5,841		(2,213)
Provision for doubtful accounts	2,101		1,018
Non-cash stock compensation	753		2,566
Amortization of deferred financing costs	24,509		18,074
Currency remeasurement (gain) loss	28,821	[1]	(4,843)	[1]
Changes in assets and liabilities:
Receivables	(11,249)		(5,544)
Inventories	(43,740)		(19,294)
Other current assets	(6,999)		(22,704)
Payables	17,516		(111,070)
Accrued expenses	69,921		52,694
Other noncurrent liabilities	(11,059)		157
Other, net	(68,329)		(10,408)
Net cash used in operating activities	(150,621)		(199,493)
Cash Flows From Investing Activities:
Capital expenditures	(76,936)		(51,378)
Insurance proceeds	0		3,461
Proceeds from asset sales	7,624		4,191
Net cash used in investing activities	(69,312)		(43,726)
Cash Flows From Financing Activities:
Decrease in short-term borrowings	(3,074)		(14,996)
Increase in other debt	196,240		270,009
Financing fees and other	16,057		29,221
Net cash provided by financing activities	177,109		225,792
Effect of exchange rate changes on cash and cash equivalents	(5,908)		1,474
Net decrease in cash and cash equivalents	(48,732)		(15,953)
Cash and cash equivalents, beginning of period	103,711		104,289
Cash and cash equivalents, end of period	54,979
Cash paid during the period:
Interest	31,006		19,188
Income taxes (net of refunds)	$ 5,929		$ 8,490

[1] The currency remeasurement (gain) loss related primarily to intercompany loans to foreign subsidiaries denominated in euros.